Editorial Compilation VI

Emmanuel J. Favaloro; Giuseppe Lippi

doi:10.1055/s-0038-1677462

Seminars in Thrombosis and Hemostasis, Table of Contents

Semin Thromb Hemost 2019; 45(01): 005-009
DOI: 10.1055/s-0038-1677462

Preface

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Editorial Compilation VI

Emmanuel J. Favaloro

¹Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, Westmead, Australia

,

Giuseppe Lippi

²Section of Clinical Biochemistry, University of Verona, Verona, Italy

› Author Affiliations

Abstract

Full Text

References

References
1 Favaloro EJ. 2011 Eberhard F. Mammen award announcements. Semin Thromb Hemost 2011; 37 (05) 431-439
2 Favaloro EJ. 2012 Eberhard F. Mammen award announcements. Semin Thromb Hemost 2012; 38 (05) 425-432
3 Favaloro EJ. 2013 Eberhard F. Mammen award announcements. Semin Thromb Hemost 2013; 39 (06) 567-574
4 Favaloro EJ. 2014 Eberhard F. Mammen award announcements: part II-Young Investigator Awards. Semin Thromb Hemost 2014; 40 (07) 718-723
5 Favaloro EJ. 2015 Eberhard F. Mammen award announcements: part II-Young Investigator Awards. Semin Thromb Hemost 2015; 41 (08) 809-815
6 Favaloro EJ. 2016 Eberhard F. Mammen award announcements: part II-Young Investigator Awards. Semin Thromb Hemost 2017; 43 (03) 235-241
7 Favaloro EJ. 2017 Eberhard F. Mammen award announcements: part II-Young Investigator Awards. Semin Thromb Hemost 2018; 44 (02) 81-88
8 Favaloro EJ. How to generate a more accurate laboratory-based international normalized ratio (INR): solutions to obtaining or verifying the mean normal prothrombin time (MNPT) and international sensitivity index (ISI). Semin Thromb Hemost 2019; 45 (01) 10-21
9 Favaloro EJ, Kershaw G, Mohammed S, Lippi G. How to optimize activated partial thromboplastin time (APTT) testing: solutions to assessing normal reference ranges and APTT reagents for sensitivity to heparin, lupus, and clotting factors. Semin Thromb Hemost 2019; 45 (01) 22-35
10 Favaloro EJ, Pasalic L, Lippi G. Replacing warfarin therapy with the newer direct oral anticoagulants, or simply a growth in anticoagulation therapy? Implications for pathology testing. Pathology 2017; 49 (06) 639-643
11 Favaloro EJ. Optimizing the Verification of Mean Normal Prothrombin Time (MNPT) and International Sensitivity Index (ISI) for Accurate Conversion of Prothrombin Time (PT) to International Normalized Ratio (INR). Methods Mol Biol 2017; 1646: 59-74
12 Kitchen DP, Jennings I, Kitchen S, Woods TA, Walker ID. Bridging the gap between point-of-care testing and laboratory testing in hemostasis. Semin Thromb Hemost 2015; 41 (03) 272-278
13 Bonar R, Mohammed S, Favaloro EJ. International normalized ratio monitoring of vitamin K antagonist therapy: comparative performance of point-of-care and laboratory-derived testing. Semin Thromb Hemost 2015; 41 (03) 279-286
14 Bonar R, Favaloro EJ. Explaining and reducing the variation in inter-laboratory reported values for international normalised ratio. Thromb Res 2017; 150: 22-29
15 Baluwala I, Favaloro EJ, Pasalic L. Therapeutic monitoring of unfractionated heparin - trials and tribulations. Expert Rev Hematol 2017; 10 (07) 595-605
16 Kershaw G. Performance of Activated Partial Thromboplastin Time (APTT): determining reagent sensitivity to factor deficiencies, heparin, and lupus anticoagulants. Methods Mol Biol 2017; 1646: 75-83
17 Stufano F, Boscarino M, Bucciarelli P. , et al. Utility of von Willebrand factor propeptide in the differential diagnosis of von Willebrand disease and acquired von Willebrand syndrome. Semin Thromb Hemost 2019; 45 (01) 36-42
18 Favaloro EJ. Diagnosis or exclusion of von Willebrand disease using laboratory testing. Methods Mol Biol 2017; 1646: 391-402
19 Dorgalaleh A, Tabibian S, Shams M. , et al. A unique factor XIII mutation in southeastern Iran with an unexpectedly high prevalence: Khash factor XIII. Semin Thromb Hemost 2019; 45 (01) 43-49
20 Alavi SER, Jalalvand M, Assadollahi V, Tabibian S, Dorgalaleh A. Intracranial hemorrhage: a devastating outcome of congenital bleeding disorders-prevalence, diagnosis, and management, with a special focus on congenital factor XIII deficiency. Semin Thromb Hemost 2018; 44 (03) 267-275
21 Carcao M, Fukutake K, Inbal A. , et al. Developing the first recombinant factor XIII for congenital factor XIII deficiency: clinical challenges and successes. Semin Thromb Hemost 2017; 43 (01) 59-68
22 Arachchillage DRJ, Makris M. Inherited thrombophilia and pregnancy complications: should we test?. Semin Thromb Hemost 2019; 45 (01) 50-60
23 Kubisz P, Holly P, Stasko J. Sticky platelet syndrome – 35 years of growing evidence. Semin Thromb Hemost 2019; 45 (01) 61-68
24 Favaloro EJ, Lippi G. Commentary: controversies in thrombosis and hemostasis part 2 - does sticky platelet syndrome exist?. Semin Thromb Hemost 2019; 45 (01) 69-72
25 Huang JY, Soeharto DA, Damara I, Ignjatovic V, Linden MD, Monagle P. Antiplatelet therapy monitoring in neonates and children. Semin Thromb Hemost 2019; 45 (01) 73-85
26 Laridan E, Martinod K, De Meyer SF. Neutrophil extracellular traps in arterial and venous thrombosis. Semin Thromb Hemost 2019; 45 (01) 86-93
27 Maclachlan KH, Stevens HP, Tran HA, Chunilal SD. Weight-based enoxaparin for venous thromboembolism in obesity gives similar anti-Xa levels to patients <100kg, with no increase in major bleeding. Semin Thromb Hemost 2019; 45 (01) 94-99
28 McCaughan GJB, Favaloro EJ, Pasalic L, Curnow J. Anticoagulation at the extremes of body weight: choices and dosing. Expert Rev Hematol 2018; 11 (10) 817-828
29 Thachil J. The elusive diagnosis of disseminated intravascular coagulation: does a diagnosis of DIC exist anymore?. Semin Thromb Hemost 2019; 45 (01) 100-107
30 Sridharan M, Coon L, Chen D, Pruthi RK, Factor V. Deficiency with a thrombotic clinical phenotype. Semin Thromb Hemost 2019; 45 (01) 108-112
31 Hoirisch-Clapauch S. Comment on “Venous and Arterial Thromboses: two sides of the same coin?”. Semin Thromb Hemost 2019; 45 (01) 113-114
32 Lippi G, Favaloro EJ. Myocardial infarction, unstable angina and white thrombi: time to move forward?. Semin Thromb Hemost 2019; 45 (01) 115-116
33 Stanciakova L, Kubisz P, Stasko J, Maly J. Meeting report: The XXVth Slovak-Czech Conference on Hemostasis and Thrombosis (with international participation), Martin, Slovak Republic. Semin Thromb Hemost 2019; 45 (01) 117-120
34 Welcome to Seminars in Thrombosis & Hemostasis. New (2017) Impact Factor and most highly cited papers. Semin Thromb Hemost 2019; 45 (01) 1-4